Xiaofen Pan

Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region–Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib

Xiaomei Ren, Xiaofen Pan, Zhang Zhang et al. · Journal of Medicinal Chemistry · 2013 · 181 citations · Full text

Medicine, Oncology, Pharmacology +13

Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis

Xiaofen Pan, Zhixiu Lin, Danxian Jiang et al. · Oncology Letters · 2019 · 115 citations · Full text

Medicine, Oncology, Pharmacology +14

Upregulation of HSPA1A/HSPA1B/HSPA7 and Downregulation of HSPA9 Were Related to Poor Survival in Colon Cancer

Yufeng Guan, Xianjun Zhu, Junjie Liang et al. · Frontiers in Oncology · 2021 · 82 citations · Full text

Medicine, Molecular Biology, Oncology +14

1-Phenyl-4-benzoyl-1<i>H</i>-1,2,3-triazoles as Orally Bioavailable Transcriptional Function Suppressors of Estrogen-Related Receptor α

Shilin Xu, Xiaoxi Zhuang, Xiaofen Pan et al. · Journal of Medicinal Chemistry · 2013 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Preoperative CT texture analysis of gastric cancer: correlations with postoperative TNM staging

S. Liu, Hua Shi, Chen Ji et al. · Clinical Radiology · 2018 · 53 citations

Medicine, Oncology, Surgery +16